Biotechnology

Evaluating the Breast Cancer Therapeutics Market

October 24, 2023 - As breast cancer awareness month continues, gathering a comprehensive understanding of the breast cancer therapeutics market is critical, including current trends and market players, gaps, and predictions for the coming year. Understanding the therapeutics market and market dynamics can help companies position themselves for prompt regulatory approval or successful market...

Read More


More Articles

New Reagent Delivers Biomolecules to Lung Tissue to Treat Lung Disease

by Veronica Salib

On August 2, 2023, Altogen Biosystems announced and launched a new targeted reagent that can deliver biomolecules to the lungs, treating pulmonary diseases. According to the announcement, the drug has...

NIH Researchers Begin Clinical Trials on a Universal Influenza Vaccine

by Veronica Salib

The NIH’s National Institute of Allergy and Infectious Disease (NIAID) Vaccine Research Center (VCR) researchers have begun phase 1 clinical trials on a universal mRNA influenza vaccine. The...

Moderna to Buy Japanese Firm OriCiro in Its First-Ever Acquisition

by Hayden Schmidt

Moderna Inc and Japan-based OriCiro Genomics K.K. reached an agreement on Wednesday wherein Moderna will acquire OriCiro and its suite of biopharmaceutical applications for $85...

First Humans Transfused with Lab-Grown Blood

by Veronica Salib

According to an announcement by the NHS, the first humans have been transfused with lab-grown red blood cells as part of the RESTORE trial. The RESTORE trial is a randomized clinical trial in which red...

Pfizer Plans to Nearly Quadruple COVID Vaccine Costs

by Veronica Salib

As the COVID-19 pandemic progresses, access and affordability to vaccines have been effective tools for public health professionals. Currently, the federal government covers COVID-19 vaccination...

Bridging Surgical Treatment and Chemoradiation for Glioblastoma Patients

by Veronica Salib

On October 11, 2022, GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for...

Patients, Providers, and the Public Hesitate to Adopt Digital Pills

by Veronica Salib

On November 13, 2017, Abilify MyCite became the first digital pill approved by the United States FDA. Since this approval and the initial surge of digital pills — sometimes called smart pills — the uptake and utilization have...

Biden Administration Appoints Renee Wegrzyn as Director of the ARPA-H

by Veronica Salib

The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...

IVF Provides Additional Resources in Reproductive Health

by Veronica Salib

The overturning of Roe v. Wade in the 2022 Dobbs v. Jackson Women’s Health Organization United State Supreme Court case has brought about a lot of conversation about reproductive rights, including in vitro fertilization (IVF). The...

Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen

by Hayden Schmidt

The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed. Initial indications that Merck was...

FDA Grants Abbott Permission to Investigate DBS in Managing Depression

by Veronica Salib

Abbott recently announced that they had been granted Breakthrough Device Designation by the FDA, which allows them to investigate the use of deep brain stimulation (DBS) in managing severe...

Revolutions in Neuroscience: Deep Brain Stimulation

by Veronica Salib

Deep brain stimulation (DBS) — a neurosurgical approach for treatment-resistant neurological disorders — has become a revolutionary addition to the field of neuroscience and a beneficial tool for neurologists, neurosurgeons,...

Vagus Nerve Stimulation Augments Behaviors in Epilepsy Patients

by Veronica Salib

Scientific Reports recently published a study that concluded transcutaneous vagus nerve stimulation (tVNS) altered cooperative behaviors in epilepsy patients. According to the Epilepsy Foundation,...

Beta Bionics Shares Clinical Trial Data on Bionic Pancreas for Type 1 Diabetes

by Veronica Salib

Earlier this month, Beta Bionics presented clinical trial data to the American Diabetes Association (ADA) on its insulin-only bionic pancreas — called the iLet Bionic Pancreas — for use in...

AstraZeneca to Open Drug Research, Development Site in MA

by Samantha McGrail

AstraZeneca recently announced plans to open a new drug research and development site at the heart of Cambridge, MA, for itself and Alexion’s new corporate headquarters. The strategic center...

Boehringer Ingelheim, Lifebit Partner to Advance Biomedical Data

by Samantha McGrail

Boehringer Ingelheim and precision medicine software company Lifebit Biotech recently partnered to build a scalable data, analytics, and infrastructure platform to unlock the transformation value of...

UC Berkeley Loses CRISPR Gene-Editing Patent Appeal

by Samantha McGrail

The US Patent and Trademark Office (PTAB) recently ruled that CRISPR gene-editing technology belongs to the Broad Institute of Harvard and MIT, according to multiple news sources. After an...

Biotech Company Launches Medical Device for Blood Transfusions

by Samantha McGrail

Biotechnology company, EryPharm, recently launched a medical device product to mass-produce cultured red blood cells and develop new sourcing for blood transfusions.  The technological...

Pfizer Invests $120M to Advance Biotechnology Innovation

by Samantha McGrail

Pfizer recently announced that it has invested $120 million in four clinical-stage companies that focus on biotechnology innovation, oncology, rare disease, and immunology treatments. Through the...

Recent Articles